TW200800890A - Method of making 8-fluoro-naphthalen-1-ylamine and related compounds - Google Patents

Method of making 8-fluoro-naphthalen-1-ylamine and related compounds Download PDF

Info

Publication number
TW200800890A
TW200800890A TW95139020A TW95139020A TW200800890A TW 200800890 A TW200800890 A TW 200800890A TW 95139020 A TW95139020 A TW 95139020A TW 95139020 A TW95139020 A TW 95139020A TW 200800890 A TW200800890 A TW 200800890A
Authority
TW
Taiwan
Prior art keywords
fluoro
group
hydrogen
ylamine
reaction
Prior art date
Application number
TW95139020A
Other languages
Chinese (zh)
Inventor
Zhijian Zhu
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of TW200800890A publication Critical patent/TW200800890A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/067Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/64Preparation of compounds containing amino groups bound to a carbon skeleton by disproportionation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/08Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

A process is described for preparing 8-flouro-napthalen-l-ylamine comprising reacting lH-naphtho[l,8-de][l,2,3]triazine with hydrogen fluoride or a complex of hydrogen fluoride and an n-donor base. A process is also set forth for using 8-fluoro- naphthalen-1-ylamine produced as described above in the preparation of l-(8-fluoro- napthalen-l-yl)-piperazine, which can be used as an intermediate in the production of 7- (4-[4-(8-fluoro-napthalen-1-yl)-piperazin-1-yl] -butoxy) -3, 4-dihydro-IH- [l,8]naphthyridin-2-one, a D2 partial agonist indicated for possible use in the treatment of schizophrenia.

Description

200800890 九、發明說明: 【發明所屬之技術領域】 、本發明係關於製備8•氟·萘小基胺、胺之方 法,關於該等化合物在7_{4例8去萘小基)·ι嗪小基]_ 丁乳基}-3,4-二氫-1/f_n,8]^_2•酮之合成中作為中間物 的用途。 【先前技術】200800890 IX. Description of the invention: [Technical field to which the invention pertains] The present invention relates to a method for preparing 8·fluoro·naphthalene-based amines and amines, and the compounds are in the form of 7_{4 cases of 8 denaphthalenes). Use of an intermediate as a compound in the synthesis of a small base]_butyl lactyl}-3,4-dihydro-1/f_n,8]^_2. ketone. [Prior Art]

美國專利申請公開案2〇〇5/〇〇433〇9A1(實例A66)揭示一 種用於合成7-{4-[4m-i-基)-派嗓-1-基]-丁氧基}_ 3,4-二氫魯n,8Mm同(一種經指明用於治療精神分裂 症之多巴胺〇2部分促進劑)之方法,在此方法中】♦氣·蔡_ 1-基)-娘嗪用作中間物。不幸地是,❹製備該特定中間 物之合成方法成本高及控制操作困難,因此不適合用於製 造大量產物。特定言之,在此方法之第一步驟中,使用8_ /臭基-奈-1-羧酸(一種極昂貴的化合物)經Curtis重排反應來 製造8-溴基-萘基胺。在此方法中所释放之大量熱使得 難以保證安全操作。在該方法之第二步驟中使用 Schiemann重氮化/氟-去重氮化反應來生產卜溴彳―氟-萘。 後使用戎反應之產物來製造1 _(8_氟_萘_丨_基)_略唤中間 物0 吾人可設想藉由使用廉價化合物形成哌嗪來由另一種8_ 鹵-萘-1-基胺中間物(8-氟-萘-1-基胺)製造1-(8-氟 旅嗪。然而,在該文獻中所揭示之用於製造該特定中間物 之方法包括諸多步驟、產生許多雜質或使用不穩定化合 I15347.doc 200800890 物。如下流程1說明在此文獻中所揭示之用於製造8_氟-萘_ 1-基胺(1)的數種方法。一種參照案描述藉由鐵還原由I 氟8~石肖基秦(3)製備化合物1(如"c/^所.万1966, 乃,577-581)。流程!亦說明在此文獻中所揭示之用於由化 合物4製造化合物1的方法。 流程1U.S. Patent Application Publication No. 2〇〇5/〇〇433〇9A1 (Example A66) discloses a method for synthesizing 7-{4-[4m-i-yl)-pyridin-1-yl]-butoxy}_ 3,4-Dihydrolu-n, 8Mm (a method for the determination of a dopamine quinone 2 moiety promoter for the treatment of schizophrenia), in this method] ♦ gas · Cai _ 1-base) - azine As an intermediate. Unfortunately, the synthesis of this particular intermediate is costly and difficult to control and therefore not suitable for use in the manufacture of large quantities of product. Specifically, in the first step of the process, 8-bromo-naphthylamine is produced by a Curtis rearrangement reaction using 8_/odor-na-l-carboxylic acid (a very expensive compound). The large amount of heat released in this method makes it difficult to ensure safe operation. In the second step of the process, a Schiemann diazonium/fluorine-deazotization reaction is used to produce bromobromine-fluoro-naphthalene. After the use of the product of the hydrazine reaction to produce 1 _(8_fluoro-naphthalene-丨-yl)_slightly intermediate 0, we can imagine the formation of piperazine by using an inexpensive compound to give another 8_halo-naphthalen-1-yl group The amine intermediate (8-fluoro-naphthalen-1-ylamine) produces 1-(8-fluoro-birthazine. However, the process disclosed in this document for making this particular intermediate involves many steps and produces many impurities. Or use the unstable compound I15347.doc 200800890. The following Scheme 1 illustrates several methods for producing 8-fluoro-naphthalene-1-ylamine (1) disclosed in this document. A reference description is made by iron. Reduction of compound 1 by I-fluoro 8~ Shi Xiao Ji Qin (3) (eg "c/^. 1966, 577-581). Flow! Also disclosed in this document for use in the manufacture of compound 4 Method of Compound 1. Scheme 1

在流程1中說明之一種方法中,藉由^氟萘(6)之硝化製 備化合物 3(Israel Journal 〇f Chemistry, 1977,16, 299- 303)。然而,硝化產生1_氟_2-硝基萘、^氟^^肖基萘及] 之混合物’且藉由管柱層析法分離產物。 在流程1中說明之另一種方法中,由8-硝基萘基胺(5) 經Schiemami反應製備化合物3(如"《Μ 1966, 75,577-581)。然而,1-萘基胺(8)之硝化僅產生5之38%產 率,同時生成5-石肖基-奈基胺^“μ 1939, 348)。亦已藉由丨^二硝基萘(7)之單還原製 I15347.doc 200800890 備化合物 ^(Collection of Czechoslovak Chemical Communicatiom, 1929,1,360)。化合物7為熱敏感及衝擊敏感的,其(尤其) 在大規模製備中限制化合物7之用途。 在流程1中說明之另一種方法中,可由氟-1-萘甲酸(2) 經Curtis或Hoffmann重排反應製備化合物i。然而,一參照 案揭示由(鄰-氟苯基)乙酸乙酯(4)製備化合物2需要五個合In one of the processes illustrated in Scheme 1, compound 3 is prepared by nitration of fluoronaphthalene (6) (Israel Journal 〇f Chemistry, 1977, 16, 299-303). However, nitration produces a mixture of 1-fluoro-2-nitronaphthalene, fluoropropanyl and a mixture and the product is isolated by column chromatography. In another method illustrated in Scheme 1, compound 3 is prepared from 8-nitronaphthylamine (5) via a Schiemami reaction (e.g. " Μ 1966, 75, 577-581). However, the nitration of 1-naphthylamine (8) yielded only 38% yield of 5, while producing 5-stone Schottyl-neglandamine "μ 1939, 348". Also by 丨^ dinitronaphthalene (7) Single reduction system I15347.doc 200800890 Preparation compound ^ (Collection of Czechoslovak Chemical Communicatiom, 1929, 1, 360). Compound 7 is heat sensitive and impact sensitive, which (especially) limits the use of compound 7 in large scale preparation In another method illustrated in Scheme 1, compound i can be prepared from a fluoro-1-naphthoic acid (2) by Curtis or Hoffmann rearrangement reaction. However, a reference discloses ethyl (o-fluorophenyl)acetate. (4) Five compounds are required to prepare compound 2

成步驟(J⑽7,⑽CTzembir;;,2002,67,1171-1177)〇 如上所見,上文所說明或所描述之反應流程無一適合實 用、女全及經濟地製備8-氟-萘-1 -基胺,其為可用於合成 諸如1-(8-氟-萘-1-基)-哌嗪或7-{4-[4-(8-氪-萘-^基卜哌嗪一 1-基]-丁氧基}-3,4-二氫-1好-[1,8] 口萘咬-2-酮之化合物的 有用之中間物。 德國專利DE147852揭示當在存在鋼及加熱條件下暴露 於濃氫氯酸及氯化氫氣體時If萘并[l58_de][1,2,3]三嗪可 轉化為8-氯基_1_胺基萘。然而,氟化物比氯化物親核性弱 之事實使吾人不期望能用氟化物替換三嗪修飾該方法來製 造8-敦-萘-i_基胺。 【發明内容】 本發明係關於一種製備8-氟-萘-i_基胺之方法。 包含使1开-萘并[1,8’[1,2,3]三.與IU匕氫或氣化氣與^ 體鹼之錯合物反應。本發明進一步係關於—種由8_氟心 1-基胺製備l-(8-|L -萘-1-基)-°底嗪之方法c 除非另有說明,否則如本文所使用之術語”烷基"包括 115347.doc 200800890 =鏈、支鏈或環部分或其組合之⑼單㈣基。"烧基" 貝例包括(但不限於)甲基、乙基、丙基、異丙基、丁 ;二丁基、第二丁基及第三丁基、戊基、己基、庚基、 :::基、環丙基、環丁基、環戊基、環己基、環庚 基、降%基及其類似基團。 除非另有說明,否則如本文所使用之術語"烧氧基"意謂 说基-〇·",其中”烧基"如上敎義。,,燒氧基"之實例包括 (但不限於)甲氧基、乙氧基、丙氧基、丁氧基及戊氧基。 除非另有說明’否則如本文所使用之術語,,鹵"及”鹵素” 包括氟、氯、溴及碘。 【實施方式】 、在-實施例中,本發明係關於—種藉由使三唤與說化氣 或與氟化氫及η供體鹼之錯合物反應而由萘并[H (^][1’2,3]二嘻製備8-氟-萘_1_基胺之方法。 在另一實施例中,η供體鹼係選自由以下各基團組成之 群:四氫呋喃、胺、醯胺、胺基曱酸、醋、三烷基膦或 醇。η供體鹼更佳為式1之化合物: i 其中R1為氫、羥基、胺基、硝基、鹵、Cl_c5烷基或cKc5 烷氧基。式1之化合物較佳為吡啶。對於討論將氟化氫及 氟化氫與η供體鹼之錯合物用作其他化合物之氟化試劑的 方法,參 ^Journal of Organic Chemistry,\9Ί9, 3 私η2& 其中所引用之參考文獻。 115347.doc 200800890 如在以下實例2中說明,根據本發明之方法將丨仏萘并 上8’[1,2,3]三噪轉化為8|萘小基胺可使用氟化氣與 成:之錯合物在比諸如描述於即147852中用來將相同三 :化為訌氯基-萘基胺更溫和之條件下來達成。因為 既化物比氯化物親核弱’所以此為令人吃驚的。此外,在Step (J(10)7, (10) CTzembir;;, 2002, 67, 1171-1177) As seen above, none of the reaction schemes described or described above are suitable for practical, female and economical preparation of 8-fluoro-naphthalene-1 Alkylamine which is useful for the synthesis of, for example, 1-(8-fluoro-naphthalen-1-yl)-piperazine or 7-{4-[4-(8-indole-naphthalene-^-piperazine-l-yl) Useful intermediates for compounds of -butoxy}-3,4-dihydro-1-[1,8]-naphthalene-2-one. German Patent DE 147 852 discloses exposure in the presence of steel and heating When concentrated hydrochloric acid and hydrogen chloride gas, If naphtho[l58_de][1,2,3] triazine can be converted to 8-chloro-1_1-aminonaphthalene. However, fluoride is weaker than chloride. The fact that we do not expect to be able to replace the triazine with fluoride to modify the process to produce 8-den-naphthalene-i-ylamine. [Invention] The present invention relates to a process for preparing 8-fluoro-naphthalene-i-ylamine. Including the reaction of 1 -naphtho[1,8'[1,2,3]. with IU 匕 hydrogen or gasification gas and alkaloid. The present invention further relates to the species by 8_ Method for preparing 1-(8-|L-naphthalen-1-yl)-pyridazine from fluorocentric 1-ylamine c Unless otherwise stated, The term "alkyl" as used includes 115347.doc 200800890 = (9) mono (tetra)yl groups of the chain, branch or ring moiety or combinations thereof. "alkyl groups" Examples include, but are not limited to, methyl, ethyl, Propyl, isopropyl, butyl; dibutyl, t-butyl and tert-butyl, pentyl, hexyl, heptyl, :::yl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl , cycloheptyl, norminyl, and the like. Unless otherwise stated, the term "alkoxy" as used herein means base-〇·", where "burning base" is as above Examples of oxime, "alkoxy" include, but are not limited to, methoxy, ethoxy, propoxy, butoxy, and pentyloxy. Unless otherwise stated, the term as used herein , "halogen" and "halogen" include fluorine, chlorine, bromine and iodine. [Embodiment] In the embodiment, the present invention relates to a method for making a triple call with a gas or with hydrogen fluoride and η. A method for preparing 8-fluoro-naphthalen-1-ylamine from naphtho[H(^][1'2,3]dioxin by reacting a complex of alkaloid. In another embodiment, η donor base Selected from a group consisting of the following groups: tetrahydrofuran, amine, decylamine, amino decanoic acid, vinegar, trialkylphosphine or alcohol. The η donor base is more preferably a compound of formula 1: i wherein R1 is hydrogen, hydroxy, amine a nitro group, a halogen, a Cl_c5 alkyl group or a cKc5 alkoxy group. The compound of the formula 1 is preferably a pyridine. A method for using a hydrogen fluoride and a complex of hydrogen fluoride and a η donor base as a fluorinating reagent for other compounds is discussed. , refer to the Journal of Organic Chemistry, \9Ί9, 3 private η2& references cited therein. 115347.doc 200800890 As illustrated in Example 2 below, the conversion of indole naphtho 8'[1,2,3] trisonic to 8|naphthalene small amine can be accomplished using a fluorinated gas as follows: The complex is achieved under conditions which are used to temper the same three: chloro-naphthylamine, as described in 147852. This is surprising because the compound is weaker than the chloride nucleophile. In addition, in

法中,料并从嗽咖嗪之表現似乎 :…匕之重氮化合物,從而允許引入氟基,但該氟 二之引入極大降低熱不穩定性.如在實例i中所述對丨扒萘 开[l,8-de]n,2,3]三嗪所進行之差示掃描熱量測定(⑽q 分析展示勒始溫度赠,能量817 J/g。此表示該化合物 具有比其他重氮化合物更大之安全處理範圍。此外,為完 成將⑽萘并n,8_de][1,2,3]三嗪轉化成8备萘小基胺,= 要求柱式純化。 當在上述本方法之實施例中將㈣用作氟化氫&供體驗 錯合物中之η供體驗時,用於該錯合物中之I化氫與吼咬 的比率較佳為70%氟化氫與30%D比咬至57%氣化氯與桃吼 啶、更佳為7〇%氟化氫與3〇%吡咬(w/w,相對於錯合物之 總重量)。 如上所述,在本發明之另一實施例中,當i扒萘并 de][l,2,3]^嘻與氟化氫或與氟化氫及n供體鹼之錯合物反 應時,較佳在-3(TC至15(TC之間的溫度、更佳在約5它至 55°C之溫度、甚至更佳在約2(rc至3(rc之温度下完成此反 應。 在另一實施例中,在溶劑存在下進行1/?•萘并 115347.doc 200800890 Π,2,3]二嗪與氟化氫或與 座 —w + 、氣及11供體驗之錯合物的斤 應。该浴劑較佳係選自 的反 ^ 乂下各溶劑組成之群:2_甲氧Α 乙知、四氫呋喃、!,心二噁 卜 Τ虱基 氧基乙烧、二n •甲基四心喃、m 氯甲炫、二氯乙炫。甲本乳本、二氯苯及二 此項技術中已知之諸多方法之杯去、益人 菸昍由夕万在之任一者適合用於製造在本 發月中所使用的1萘养 Α ,、开[,8-de]n,2,3]三嗪。較佳由 J 8·In the process, it is expected that the performance of bismuthazine is: 匕 diazonium compound, thereby allowing the introduction of a fluorine group, but the introduction of the fluorine II greatly reduces the thermal instability. As described in Example i Differential scanning calorimetry performed by [l,8-de]n,2,3]triazine ((10)q analysis shows initial temperature, energy 817 J/g. This means that the compound has more than other diazonium compounds. Large safe treatment range. In addition, in order to complete the conversion of (10) naphtho-n,8_de][1,2,3]triazine to 8-naphthalene-based amine, = column purification is required. When the intermediate (4) is used as hydrogen fluoride & for the experience of η in the complex, the ratio of hydrogen to the bite used in the complex is preferably 70% hydrogen fluoride and 30% D bite to 57. % gasified chlorine and acridine, more preferably 7% hydrogen fluoride and 3% pyridene (w/w, relative to the total weight of the complex). As mentioned above, in another embodiment of the invention When i扒naphthalene de][l,2,3]^嘻 is reacted with hydrogen fluoride or a complex with hydrogen fluoride and n donor base, preferably at -3 (TC to 15 (temperature between TC, Better at about 5 it to 55° The temperature of C, even more preferably, is about 2 (rc to 3 (temperature of rc). In another embodiment, 1/? naphthalene is used in the presence of a solvent. 115347.doc 200800890 Π, 2, 3 Dioxazine and hydrogen fluoride or a complex of w-w, gas and 11 for the experience of the complex. The bath is preferably selected from the group consisting of various solvents: 2_methoxy oxime Know, tetrahydrofuran, !, heart dioxin, oxime acetophenone, di n, methyl tetracycline, m chloromethyl chloro, dichloro ethane, chlorpyrifos, dichlorobenzene and two The cups of many known methods, such as the ones used in the production of this month, are suitable for the production of 1 naphthene, [8-de]n, 2, 3] Triazine. Preferably by J 8·

一胺基萘製㈣.萘朴从m灿三嗔。用於由心 胺基蔡製備他萘并w]n,2,取嗪之合適程序描述於· ,郎/ 0/咖 —·吟,1969, 756 中。1,8二胺基 不與8^臭基·奈+魏酸相比為用於製造8备萘小基胺(經 由祭并[l,8-de][l,2,3]三嗪中間物)之廉價起始物質,8_ 溴基-萘-1-羧酸為在US2〇〇5/〇〇433〇9A1之實例A"中所揭 示用於製造M8-氟-萘小基)派嗪的方法中之起始物質。此 .卜使用本發明之方法合成8-氟-萘-1-基胺與在文獻中所 描述之方法相比需要較少合成步驟、較少純化步驟及較溫 和的反應條件。 在另一實施例中,本發明之方法進一步包含使如上所述 生產之8-氟-1-胺基萘與雙(2-氯乙基胺)鹽酸鹽反應以生產 1-(8 -氟-奈-1-基)旅噃。在如下之流程2之反應流程中說明 本方法之較佳實施例(以1,8-二胺基萘起始): •10- 115347.doc 200800890 流程2 ,2亞硝酸異戊雖 _ ElDM,如OH、室溫Monoamine naphthalene (4). Naphthyl from mcan. A suitable procedure for the preparation of naphthyl and w]n,2, from the amine amine-based C., is described in lang, 0/ca- 吟, 1969, 756. The 1,8-diamine group is not used in the manufacture of 8 naphthalene-based amines compared to 8^, odor, naphthyl, and acenamic acid (via the [l,8-de][l,2,3]triazine intermediate The inexpensive starting material, 8_bromo-naphthalene-1-carboxylic acid, is disclosed in the example A" of US 2 〇〇 5/〇〇 433 〇 9 A1 for the manufacture of M8-fluoro-naphthalene small group) The starting material in the method. The synthesis of 8-fluoro-naphthalen-1-ylamine using the process of the present invention requires less synthesis steps, less purification steps, and milder reaction conditions than the methods described in the literature. In another embodiment, the process of the present invention further comprises reacting 8-fluoro-1-aminonaphthalene produced as described above with bis(2-chloroethylamine) hydrochloride to produce 1-(8-fluoro) - Nai-1-ki) Travel. A preferred embodiment of the process (starting with 1,8-diaminonaphthalene) is illustrated in the reaction scheme of Scheme 2 below: • 10 - 115347.doc 200800890 Scheme 2, 2 pentylene nitrite _ ElDM, Such as OH, room temperature

(82-88%)(82-88%)

cS (87挪4》 NH2 F HB吡啶,室溫cS (87 Nor 4) NH2 F HB pyridine, room temperature

ί M乙基 _s_,己 ®M Methyl _s_, 己 ®

Cl-苯,遍·Cl-benzene, all over

在流程1中說明之製造8-氟-萘-1-基胺之方法中,使8-氟-萘-1-基胺在碘化四丁基銨存在下與雙(2-氯乙基)胺鹽酸鹽 反應。如在流程2中所展示,較佳在回流下在己醇與氯苯 之混合物中進行此最後反應步驟。 藉由下列實例進一步說明本發明。該等實例意欲說明本 發明且不應用來限制或侷限其範疇。在下列實例中,術語 "室溫’’係指20°C至27°C之溫度。 實例In the process for producing 8-fluoro-naphthalen-1-ylamine described in Scheme 1, 8-fluoro-naphthalen-1-ylamine is bis(2-chloroethyl) in the presence of tetrabutylammonium iodide Amine hydrochloride reaction. As shown in Scheme 2, this final reaction step is preferably carried out in a mixture of hexanol and chlorobenzene under reflux. The invention is further illustrated by the following examples. The examples are intended to illustrate the invention and should not be used to limit or limit the scope thereof. In the following examples, the term "room temperature' refers to a temperature of from 20 °C to 27 °C. Instance

實例1-製備1H-萘并[l,8-de][l,2,3]三嗪Example 1 - Preparation of 1H-naphtho[l,8-de][l,2,3]triazine

亞硝酸異戊雖 Earn誠ϋ麵Iso-nitrite, although Earn is sincere

於室溫下在氮中將1,8-二胺基萘(250 g,1.58莫耳)溶解於 乙酸(500 ml)與乙醇(2500 ml)之混合物中。隨後在維持於 18°C與21t:之間的反應混合物之溫度下經3.5小時之時段 逐滴添加亞确酸異戊酯(208.1 mL、1.55莫耳、0.98當量)。 添加後,於室溫下攪拌所得紅色懸浮液19小時。藉由過濾 115347.doc -11 - 200800890 收集固體,用乙醇(2x500 ml)洗滌且在真空下乾燥以產生 呈紅色結晶固體之1H-萘并[l,8-de][l,2,3]三嗪(235.86 g, 88%)。1H NMR (400 MHz,DMSO-D6) δ ppm 13·24 (s,m), 7·24 (m,2H),7.11 (m,1H),7·01 (d,J=8/40 Hz,1H),6·86 (dd? J 5.37? 2.64 Hz, 1H), 6.10 (d, J-7.23 Hz, 1H) ° CHN 分析:C1gH7N3 之計算值:c% 70.99、H% 4.17、N% 24.84 ;實驗值:c% 7〇.62、H〇/〇 4 〇6、24.46。 實例h製備8-氟-萘-1-基胺1,8-Diaminonaphthalene (250 g, 1.58 mol) was dissolved in a mixture of acetic acid (500 ml) and ethanol (2500 ml) in nitrogen at room temperature. Subsequently, isoamyl myristate (208.1 mL, 1.55 mol, 0.98 equivalent) was added dropwise over a period of 3.5 hours while maintaining the temperature of the reaction mixture between 18 ° C and 21 t. After the addition, the resulting red suspension was stirred at room temperature for 19 hours. The solid was collected by filtration 115347.doc -11 - 200800890, washed with ethanol (2×500 ml) and dried under vacuum to yield 1H-naphtho[l,8-de][l,2,3] as a red crystalline solid. Triazine (235.86 g, 88%). 1H NMR (400 MHz, DMSO-D6) δ ppm 13·24 (s, m), 7·24 (m, 2H), 7.11 (m, 1H), 7·01 (d, J=8/40 Hz, 1H),6·86 (dd? J 5.37? 2.64 Hz, 1H), 6.10 (d, J-7.23 Hz, 1H) ° CHN Analysis: Calculated value of C1gH7N3: c% 70.99, H% 4.17, N% 24.84; Experimental values: c% 7〇.62, H〇/〇4 〇6, 24.46. Example h Preparation of 8-fluoro-naphthalen-1-ylamine

MFP比啶 將氟化氫比啶(70% HF/3〇%吡啶,4〇()就)置於一容器 中且在冰浴中冷卻。緩慢添加1扒萘并[1,8-心][1,2,3]三嗪 (1〇〇 g,0.59莫耳)。添加後,以另外1〇〇 g氟化氫_吡啶沖洗 容器以洗去容器側壁上之固體。密封容器且將其連接於一 氮管線。於室溫下在氮中攪拌此溶液7天。高壓液相層析 ("HPLC”)分析展示在該時段結束時所有起始物質已消失, 產物純度為94%。在冰浴中冷卻該反應。一旦溫度低於… °c,缓慢添加氫氧化鉀(”koh,,)(45 w%,135 L)且使溫度 維持在低於35°C下。最終pH值約為η。 以乙酸乙酯(”EtOAc”)(5〇〇 mL)稀釋所得混合物且攪拌2〇 分鐘,且藉由一系列分離步驟自該混合物中分離產物。藉 由抽吸將混合物轉移至6_L分液漏斗中。分離水層且將其 移除。藉由CeUte⑧(石夕藻土)過據有機層及乳液界面以移除 115347.doc -12- 200800890 固體。以乙酸乙酯(2x200 mL)洗滌濾餅。分離該雙層濾出 液(此時良好分離)。以飽和氯化納(300 mL)、水(300 mL) 與飽和碳酸氫鈉(300 mL)之混合物洗滌有機層兩次;隨後 以飽和氯化鈉(300 mL)洗滌該有機層。隨後藉由氣泡氮 (bubbling nitrogen)將有機層脫氣20分鐘以移除氧且防止氧 化。溶液在氮下與活性碳(Sigma-Aldrich,242276,Darco, G-60,100目,50 g)—起攪拌5小時,且在氮下與另外之活 性碳(50 g)—起攪拌過夜。藉由Celite®過濾移除活性碳, 以EtOAc(2x300 mL)洗條固體濾餅。濃縮濾液(酒紅色)以 產生油狀物,使其與氯苯共沸兩次(2 X500 mL)。此油狀物 在室溫下靜置過夜後固化。進一步在真空中乾燥固體以產 生呈紅棕色固體之8-氟萘基胺(86. 1 g,90.4%)。1H NMR (400 MHz,DMSO-D6) δ ppm 7.48 (dd,J=8Hz,1H), 7.27 (m,1H),7.19 (t,1H),7.03 (m,2H),6.65 (dd,J=8Hz, IH)、5.66 (s,2H)。' CHN分析:C1()H8FN之計算值:C% φ 74.52,H% 5.00,N% 8.69 ;實驗值:C% 74.36,H% 4.92, N% 8.79 〇 實例3-製備1-(8-氟-萘-1·基)哌嗪鹽酸鹽。MFP is pyridine. Hydrogen fluoride is placed in a vessel with a pyridine (70% HF/3〇% pyridine, 4 〇) and cooled in an ice bath. 1扒Naphtho[1,8-heart][1,2,3]triazine (1〇〇 g, 0.59 mol) was slowly added. After the addition, the vessel was rinsed with an additional 1 〇〇 g of hydrogen fluoride pyridine to wash away the solids on the side walls of the vessel. The vessel is sealed and connected to a nitrogen line. This solution was stirred in nitrogen for 7 days at room temperature. High pressure liquid chromatography ("HPLC") analysis showed that at the end of the period all starting materials had disappeared and the product purity was 94%. The reaction was cooled in an ice bath. Once the temperature was below ... °c, hydrogen was slowly added. Potassium oxide ("koh,,") (45 w%, 135 L) and maintained at a temperature below 35 °C. The final pH is approximately η. The resulting mixture was diluted with ethyl acetate ("EtOAc") (5 mL) and stirred for 2 min and product was isolated from the mixture by a series of separation steps. The mixture was transferred to a 6-L separatory funnel by suction. The water layer is separated and removed. The solid layer and emulsion interface were removed by CeUte8 (Shiyoshizao) to remove 115347.doc -12-200800890 solids. The filter cake was washed with ethyl acetate (2 x 200 mL). The two-layer filtrate was separated (good separation at this time). The organic layer was washed twice with a mixture of saturated sodium chloride (300 mL), water (300 mL) and saturated sodium hydrogen carbonate (300 mL); The organic layer was then degassed by bubbling nitrogen for 20 minutes to remove oxygen and prevent oxidation. The solution was stirred with activated carbon (Sigma-Aldrich, 242276, Darco, G-60, 100 mesh, 50 g) under nitrogen for 5 hours and stirred with additional active carbon (50 g) under nitrogen overnight. The activated carbon was removed by filtration through Celite® and the solid cake was washed with EtOAc (2×300 mL). The filtrate (wine) was concentrated to give an oil which was azeotroped twice with chlorobenzene (2 X 500 mL). This oil was solidified after standing at room temperature overnight. The solid was further dried in vacuo to give 8-fluoronaphthylamine (86.1 g, 90.4%) as a reddish brown solid. 1H NMR (400 MHz, DMSO-D6) δ ppm 7.48 (dd, J = 8 Hz, 1H), 7.27 (m, 1H), 7.19 (t, 1H), 7.03 (m, 2H), 6.65 (dd, J = 8Hz, IH), 5.66 (s, 2H). 'CHN analysis: Calculated value of C1()H8FN: C% φ 74.52, H% 5.00, N% 8.69; Experimental value: C% 74.36, H% 4.92, N% 8.79 〇 Example 3 - Preparation of 1-(8-fluorine -Naphthalen-1-yl)piperazine hydrochloride.

雙(氛乙基)胺HC1 Bll4Ni(0. 5當重)己醇 氛苯 回流 於無水氯苯中(Aldrich,1950 mL)將8-氟-萘-1-基胺 (168.86 g,1.048莫耳)與雙(2-氯乙基)胺鹽酸鹽(Aldrich, 115347.doc -13- 200800890 B38503, 202.0 g,1· 13莫耳,1.08當量)、碘化四丁基銨 (Aldrich,140775,193.5 g,0.524 mmol,0.5 當量)及己醇 (Aldrich,1 00 mL)混合。藉由氣泡氮將該混合物脫氣20分 鐘。隨後於氮下將混合物加熱至回流歷時74小時以產生淡 棕色懸浮液。藉由HPLC檢測反應進程。使懸浮液缓慢冷 卻至室溫同時輕輕攪動隔夜以產生良好的棕色懸浮液。Bis(Ethylethyl)amine HC1 Bll4Ni (0.5 weight) hexanol was refluxed in anhydrous chlorobenzene (Aldrich, 1950 mL). 8-Fluoro-naphthalen-1-ylamine (168.86 g, 1.048 mol) And bis(2-chloroethyl)amine hydrochloride (Aldrich, 115347.doc -13- 200800890 B38503, 202.0 g, 1.9 mol, 1.08 equivalent), tetrabutylammonium iodide (Aldrich, 140775, 193.5 g, 0.524 mmol, 0.5 eq.) and hexanol (Aldrich, 100 mL) were combined. The mixture was degassed by bubbling nitrogen for 20 minutes. The mixture was then heated to reflux for 74 hours under nitrogen to give a pale brown suspension. The progress of the reaction was checked by HPLC. The suspension was slowly cooled to room temperature while gently agitating overnight to give a good brown suspension.

藉由過濾收集固體,以氯苯(300 ml)、甲苯(30〇1111)洗滌 且在室溫真空下乾燥該固體24小時以產生黃色固體。於 CH3CN(2x500 mL)中在室温下漿化粗產物4至5小時。藉由 過濾收集固體,在室溫真空下乾燥該固體以產生呈黃色固 體之1-(8-氟·萘-1-基)哌嗪鹽酸鹽(213.52 g,76·4%)。1H NMR (400 MHz? DMSO-D6) δ ppm 9.34 (bs5 2H), 7.70 (dd? J=8Hz5 1H)? 7.62 (m? 1H)? 7.43 (m? 2H)? 7.22 (m5 1H)? 7.10 (dd,J = 8Hz,1H),3.33 (m,4H),3.11 (m,2H),3.00 (m, 2H)。HPLC: 96.4%,純度(Tr=10.28分鐘,波長215 nm; YMC PackPre C18,15〇x4.6 mm,3 μιη ;溶劑 A: 0.2% HCl〇4於90:10水:CAN中,溶劑B: ACN ;梯度:30分鐘内 90A %至5%A,隨後保持5分鐘;流動速率:1 ·0 mL/min。 元素分析:C14H15FN7+1.05HC1+0.6H20 之計算值:C% 60.19、H% 6.22、N% 10.03、C1% 13.32 ;實驗值:C% 59.95、H% 6.09、N% 10.16、C1% 13.62 〇 115347.doc •14-The solid was collected by filtration, washed with chlorobenzene (300 ml), toluene (30? The crude product was slurried in CH3CN (2 x 500 mL) at room temperature for 4 to 5 hours. The solid was collected by filtration, and the solid was dried under vacuo to afford 1-(8-fluoro-naphthalen-1-yl)piperazine hydrochloride (213.52 g, 76. 4%) as a yellow solid. 1H NMR (400 MHz? DMSO-D6) δ ppm 9.34 (bs5 2H), 7.70 (dd? J=8Hz5 1H)? 7.62 (m? 1H)? 7.43 (m? 2H)? 7.22 (m5 1H)? 7.10 ( Dd, J = 8 Hz, 1H), 3.33 (m, 4H), 3.11 (m, 2H), 3.00 (m, 2H). HPLC: 96.4%, purity (Tr = 10.28 min, wavelength 215 nm; YMC PackPre C18, 15 〇 x 4.6 mm, 3 μιη; Solvent A: 0.2% HCl〇4 at 90:10 water: CAN, solvent B: ACN; Gradient: 90A % to 5% A in 30 minutes, followed by 5 minutes; Flow rate: 1 · 0 mL / min. Elemental analysis: Calculated value of C14H15FN7 + 1.05HC1 + 0.6H20: C% 60.19, H% 6.22 , N% 10.03, C1% 13.32; Experimental values: C% 59.95, H% 6.09, N% 10.16, C1% 13.62 〇115347.doc • 14-

Claims (1)

200800890 十、申請專利範圍: 1· 一種製備8-氟-萘基胺之方法,其包含 使1仏萘并[1 Ue] [ 1,2,3]三嗓與氟化氫或氟化氫與^供 體鹼之錯合物反應以產生該8-氟-萘-1-基胺。 2·如明求項1之方法,其中該η供體鹼係選自由以下各物組 成之群·經取代之四氫呋喃、胺、醯胺、胺基甲酸、 西曰、二燒基膦及醇。200800890 X. Patent application scope: 1. A method for preparing 8-fluoro-naphthylamine, which comprises 1 仏 naphtho[1 Ue] [ 1,2,3] triterpene with hydrogen fluoride or hydrogen fluoride and donor base The complex is reacted to produce the 8-fluoro-naphthalen-1-ylamine. 2. The method according to claim 1, wherein the η donor base is selected from the group consisting of tetrahydrofuran, amine, decylamine, carbamic acid, guanidine, dicalcium phosphine and an alcohol. 3·如喷求項2之方法,其中該η供體鹼為式1之化合物: R1 1 Ο 其中R1為氫 C1-C5烷氧基。 說基、胺基、石肖基、鹵、C ! - C 5烧基或 4 ·如請求項3夕 、<方法,其中該η供體鹼為吡啶。 5 · 如δ青求項4之古 、 万法’其中該氟化氫與吡啶之錯合物且 約70〇/〇氣化氫…⑻及观吼咬加/句。 6.如請求項1之古 ^ 、,八中該1抒-萘并[l,8-de][l,2,3]三嗪 獻A化風4或访支^ 。 〃、 虱及n供體驗之錯合物的反應於-30。〇 150c之間的溫度下進行。 7·如請求項6 古 .„ . 方法/其中該1开-萘并[1,8-心][1,2,3]三嗓 鼠化氧或邀蠡外—U ά〇γλ ^ 虱及η供體鹼之錯合物的反應於201 之間的溫度下進行。 8 ·如請求項工.土 氣化氣或與氟化^中該1仏蔡并[1,8_de][1,2,3]三嗓 在下進, 氫及n供體驗之錯合物的反應在溶齋 115347.doc 200800890 9、如請求項R 、之方法,其中該溶劑 之群·· 2、甲氧其,^ d係選自由以下各物組成 氫呋喃、11-t W〜烷、2-甲基四 苯、氣笨 基乙烧、二乙二醇二甲基喊、甲 乳本、二氯苯、二 10· —種製備氣_ 軋G杌 -奈小基)-哌嗪之方法,其包含. a) 根據如請求項丨之 /、 · b) 使w# 々錢備8H1_基胺,及 定口茨8-氣-奈-n 11 ^ 土私:一雙(2_氣乙基)胺踏酸蹿f處 11·如請求項10之方汰^ 签;妝鹽I鹽反應。 四 基銨存在下與該雙基胺在峨化 又^虱乙基)胺鹽酸鹽反應。 II5347.doc 200800890 七、指定代表圖: (一) 本案指定代表圖為:(無) (二) 本代表圖之元件符號簡單說明: • 八、本案若有化學式時,請揭示最能顯示發明特徵的化學式: (無)3. The method of claim 2, wherein the η donor base is a compound of formula 1: R1 1 Ο wherein R1 is hydrogen C1-C5 alkoxy. A base, an amine group, a succinyl group, a halogen, a C?-C5 alkyl group or a group according to claim 3, wherein the η donor base is pyridine. 5 · For example, δ 青 项 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 6. As in Item 1 of the ancient ^,, the eight in the 1 抒-naphtho[l,8-de][l,2,3] triazine A A wind 4 or visit branch ^. The reaction of 〃, 虱 and n for the complex is at -30. Perform at a temperature between 〇 150c. 7. If the request item 6 is ancient. „ . Method / where the 1 open-naphtho[1,8-heart][1,2,3] three moles of oxygen or invites outside -U ά〇γλ ^ 虱The reaction of the η donor base complex is carried out at a temperature between 201. 8 · As requested by the project worker. Rustic gas or with fluorinated ^1 仏 并 [1,8_de][1,2, 3] Three squats are in the process of hydrogen, and the reaction of hydrogen and n is experienced in the dissolution of the solvent. 115347.doc 200800890 9. The method of claim R, wherein the group of solvents · 2, methoxy, ^ d It is selected from the group consisting of hydrogen furan, 11-t W-alkane, 2-methyltetraphenyl, acetophenone, diethylene glycol dimethyl sulfonate, methyl milk, dichlorobenzene, and bis. - a method for preparing gas _ rolling G 杌 - nai ki) piperazine, which comprises: a) according to the request item 、 /, · b) make w# 々 备 8 8H1_ ylamine, and Dingkou 8-气-奈-n 11 ^ 土私: a pair of (2_ gas ethyl) amine stepping acid 蹿 f at 11 · as requested in the paragraph 10 of the side of the sign; makeup salt I salt reaction. Reacts with the bis-amine in deuterated and ethyl hydrazine hydrochloride. II5347.doc 200800890 VII (1) The representative representative of the case is: (none) (2) The symbol of the symbol of the representative figure is simple: • 8. If there is a chemical formula in this case, please disclose the chemical formula that best shows the characteristics of the invention: ) 115347.doc115347.doc
TW95139020A 2005-10-24 2006-10-23 Method of making 8-fluoro-naphthalen-1-ylamine and related compounds TW200800890A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72953005P 2005-10-24 2005-10-24

Publications (1)

Publication Number Publication Date
TW200800890A true TW200800890A (en) 2008-01-01

Family

ID=37885854

Family Applications (1)

Application Number Title Priority Date Filing Date
TW95139020A TW200800890A (en) 2005-10-24 2006-10-23 Method of making 8-fluoro-naphthalen-1-ylamine and related compounds

Country Status (4)

Country Link
JP (1) JP2007119461A (en)
AR (1) AR056154A1 (en)
TW (1) TW200800890A (en)
WO (1) WO2007049124A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023007515A (en) * 2019-12-10 2023-01-19 国立大学法人京都大学 Luminescent material, organic luminescent element and compound

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE147852C (en) *

Also Published As

Publication number Publication date
AR056154A1 (en) 2007-09-19
JP2007119461A (en) 2007-05-17
WO2007049124A1 (en) 2007-05-03

Similar Documents

Publication Publication Date Title
JP6061158B2 (en) Synthesis intermediate of 6- (7-((1-aminocyclopropyl) methoxy) -6-methoxyquinolin-4-yloxy) -N-methyl-1-naphthamide, or a pharmaceutically acceptable salt thereof, and its use
JP2017522306A (en) Method for producing 3- (3-chloro-1H-pyrazol-1-yl) pyridine
JP5188501B2 (en) Method for purifying montelukast and its amine salts
JP2017523168A (en) Method for producing 3- (3-chloro-1H-pyrazol-1-yl) pyridine
JP2013544769A (en) Method for synthesizing 2-substituted-1,4-benzenediamine
JP5916721B2 (en) Synthetic method of ferroquine by intensive reductive amination
JP2009513569A (en) A new chemical method for the synthesis of quinoline compounds.
JP2006070034A (en) Method for producing 2-aminopyridine derivative
TW200800890A (en) Method of making 8-fluoro-naphthalen-1-ylamine and related compounds
US20170145001A1 (en) Processes for preparing brexpiprazole
JP2019507156A (en) Process for producing 4-alkoxy-3-hydroxypicolinic acid
KR101744046B1 (en) Process for preparing an intermediate useful for the synthesis of silodosin
JP6228210B2 (en) Method for purifying fluvoxamine free base and method for producing high purity fluvoxamine maleate using the same
CN1138756C (en) Preparation of tirt nitrile substituted aromatic compound
JP6375374B2 (en) Method for producing pyrimidine intermediate
JP6506330B2 (en) Process for producing arylamines
TWI844663B (en) Process for the production of substituted 2-[2-(phenyl)ethylamino]alkaneamide derivatives
JP2016169165A (en) Method for producing 2,6-difluorobenzoylformate compound
JP2004262863A (en) Method for producing orthobenzidine compound
JP2016513091A (en) Method for producing (+)-tricyclohydroxylactone
JP2018062513A (en) Method for producing sulfonamide compound
JP5026104B2 (en) Carbazole compounds
JP2011519919A (en) Catalytic process for asymmetric hydrogenation
TWI631104B (en) Production method of 2-amino nicotinic acid benzyl ester derivative
WO2009045489A2 (en) Process for the synthesis of cmhtp, a paliperidone intermediate